Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,619.42
(
-0.56%
)
News Focus
News Focus
Post# of 257579
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 96906

Wednesday, 07/28/2010 6:18:10 AM

Wednesday, July 28, 2010 6:18:10 AM

Post# of 257579
FDA grants priority review for Merck KGaA’s Cladribine in RRMS:

http://www.reuters.com/article/idCNN2720940320100727

The PDUFA date is on or about 12/5/10 (Merck KGaA is not disclosing the exact date).

A decision on Cladribine from the EMA is expected in 3Q10. The MAA was submitted in Jul 2009 (#msg-39836037).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today